Journal
MOLECULAR NEUROBIOLOGY
Volume 60, Issue 1, Pages 303-316Publisher
SPRINGER
DOI: 10.1007/s12035-022-03066-0
Keywords
Neurodegeneration; Quantitative proteomics; Neuroprotection; Bacopa monnieri; Centella asiatica; Amyloid toxicity; Mitochondrial dysfunction
Categories
Ask authors/readers for more resources
Accumulation of A beta(42) peptides forming plaque in various regions of the brain is a characteristic of Alzheimer's disease progression. However, there is currently no effective management strategy for attenuating the early-stage toxicity induced by A beta(42). This study investigated the neuroprotective effects of aqueous extracts from Bacopa monnieri and Centella asiatica (both commonly known as Brahmi) using a Drosophila melanogaster model. Through quantitative proteomics analysis, the study found that the Brahmi extract restored the expression of a significant portion of differentially expressed proteins in A beta(42)-expressing flies, which are involved in neuronal pathways associated with cell cycle re-entry, apoptosis, and mitochondrial dynamics. The neuroprotective effect of Brahmi was also confirmed by negative geotaxis behavioral analysis. These findings provide a platform for developing novel therapies for Alzheimer's disease by elucidating the molecular targets of neuroprotection conferred by the aqueous extracts of Bacopa monnieri or Centella asiatica.
Accumulation of A beta(42) peptides forming plaque in various regions of the brain is a hallmark of Alzheimer's disease (AD) progression. However, to date, there is no effective management strategy reported for attenuation of A beta(42)-induced toxicity in the early stages of the disease. Alternate medicinal systems such as Ayurveda in the past few decades show promising results in the management of neuronal complications. Medhya Rasayana such as Brahmi is known for its neuroprotective properties via resolving memory-related issues, while the underlying molecular mechanism of the same remains unclear. In the present study, we aimed to understand the neuroprotective effects of the aqueous extract of Bacopa monnieri and Centella asiatica (both commonly known as Brahmi) against the A beta(42) expressing model of the Drosophila melanogaster. By applying a quantitative proteomics approach, the study identified > 90% of differentially expressed proteins from A beta(42) expressing D. melanogaster were either restored to their original expression pattern or showed no change in expression pattern upon receiving either Brahmi extract treatment. The Brahmi restored proteins were part of neuronal pathways associated with cell cycle re-entry, apoptosis, and mitochondrial dynamics. The neuroprotective effect of Brahmi was also validated by negative geotaxis behavioral analysis suggesting its protective role against behavioral deficits exerted by A beta(42) toxicity. We believe that these discoveries will provide a platform for developing novel therapeutics for AD management by deciphering molecular targets of neuroprotection conferred by an aqueous extract of Bacopa monnieri or Centella asiatica.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available